Open-Label, Randomized, Multicenter, Phase III Study Comparing Oral Paclitaxel Plus Encequidar Versus Intravenous Paclitaxel in Patients With Metastatic Breast Cancer

    July 2022 in “ Journal of Clinical Oncology ”
    Hope S. Rugo, Gerardo Umanzor, Feliciano Barrios, Rosa H. Vasallo, Marco A. Chivalan, Suyapa Bejarano, J. Ramírez, Luis Fein, Rubén Dario Kowalyszyn, E Douglas Kramer, Hui Wang, Min-Fun Rudolf Kwan, David L. Cutler
    TLDR Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.
    The study compared oral paclitaxel plus encequidar (oPac + E) to intravenous paclitaxel (IVpac) in 402 women with metastatic breast cancer. Results showed that oPac + E had a higher confirmed tumor response rate (36% vs. 23%) and longer median progression-free survival (8.4 months vs. 7.4 months) compared to IVpac. Overall survival was also longer for oPac + E (22.7 months vs. 16.5 months). While both treatments had similar rates of grade 3-4 adverse reactions, oPac + E had lower rates of neuropathy and alopecia but higher rates of gastrointestinal toxicity and neutropenic complications. The study concluded that oPac + E increased tumor response and had less neuropathy but more serious infections compared to IVpac.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

      community DHT and 5AR respect post, it's importance within the brain

      in Research/Science  111 upvotes 8 months ago
      The conversation discusses whether to use finasteride for hair loss, considering its role in inhibiting DHT and 5AR, which can affect brain function and mood. Some users report anxiety and depression from finasteride, while others do not experience these side effects and emphasize the importance of DHT for brain and prostate health.

      community Medications that cause extra hair growth

      in Research/Science  123 upvotes 1 year ago
      The post discusses the side effects of various drugs causing excess hair growth, questioning why only minoxidil is used in the hair loss industry. The conversation includes users sharing their experiences and concerns about potential side effects of these drugs, with some preferring baldness over potential health risks.

      community Alopecia Areata Question

      in Treatment  2 upvotes 3 years ago
      A user with alopecia totalis, borderline universalis, seeks advice on getting into a Xeljanz trial or appealing insurance for coverage. They experienced significant hair regrowth but are now seeing hair loss again and want to try Xeljanz.

    Similar Research

    5 / 1000+ results